Skip to main content
. 2011 Mar 27;4:12. doi: 10.1186/1756-8722-4-12

Table 1.

Pre-treatment patient characteristics

# Age Race PSA (ng/mL) T Stage Gleason Score Risk Group Prostate Volume (cc) AUA SHIM
1 60 Cau 4.7 1c 3+3 Low 53 3 20

2 69 Cau 6.8 1c 3+4 Intermediate 46 3 14

3 69 Cau 6.1 1c 3+3 Low 29 9 1

4 60 Cau 4.5 1c 3+3 Low 21 3 18

5 71 AA 4.0 1c 2+3 Low 31 16 19

6 72 Cau 5.6 1c 3+3 Low 41 4 1

7 56 AA 5.7 1c 3+3 Low 43 9 16

8 70 Cau 4.9 1c 3+3 Low 23 4 21

9 74 Cau 4.9 1c 3+3 Low 45 10 15

10 78 Cau 8.1 2b 3+3 Intermediate 33 1 3

11 71 Cau 4.9 1c 3+3 Low 33 5 20

12 58 AA 7.9 1c 3+4 Intermediate 37 12 21

13 66 Cau 10.3 1c 3+3 Intermediate 34 14 25

14 74 AA 6.3 1c 4+3 Intermediate 55 9 4

15 70 Cau 6.8 1c 3+3 Low 30 21 20

16 62 Cau 4.0 1c 3+4 Intermediate 30 1 25

17 79 Cau 2.3 2b 3+4 Intermediate 52 5 3

18 48 AA 6.8 1c 3+3 Low 18 8 24

19 73 Cau 6.9 1c 3+4 Intermediate 40 3 4

20 62 Cau 5.6 1c 3+3 Low 25 6 23

21 63 AA 6.2 1c 3+4 Intermediate 42 4 15

22 69 AA 5.8 1c 3+4 Intermediate 42 6 18

23 71 AA 5.9 1c 3+3 Low 34 2 24

24 65 Cau 7.4 1c 4+3 Intermediate 33 7 24

25 78 AA 4.2 2b 4+3 Intermediate 37 10 1

26 67 Cau 4 2a 3+3 Low 49 5 20

Abbreviations: Cau - Caucasian; AA - African American; AUA - American Urology Association; SHIM - sexual health inventory for men.